Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.
Menghi F, Banda K, Kumar P, Straub R, Dobrolecki L, Rodriguez IV, Yost SE, Chandok H, Radke MR, Somlo G, Yuan Y, Lewis MT, Swisher EM, Liu ET. Menghi F, et al. Among authors: banda k. Sci Transl Med. 2022 Jul 6;14(652):eabn1926. doi: 10.1126/scitranslmed.abn1926. Epub 2022 Jul 6. Sci Transl Med. 2022. PMID: 35857626 Free PMC article.
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing.
Gray HJ, Chatterjee P, Rosati R, Appleyard LR, Durenberger GJ, Diaz RL, Swan HA, Peretti D, Pollastro M, Ainge T, Kapeli K, Pereira S, Margossian AL, Banda K, Goff BA, Swisher EM, Bernard B, Kemp CJ, Grandori C. Gray HJ, et al. Among authors: banda k. NPJ Precis Oncol. 2023 May 18;7(1):45. doi: 10.1038/s41698-023-00379-8. NPJ Precis Oncol. 2023. PMID: 37202426 Free PMC article.
Exemestane induced cholestatic liver injury - A case report.
Fritzsche D, Indorf A, Miske A, Banda K. Fritzsche D, et al. Among authors: banda k. J Oncol Pharm Pract. 2021 Jun;27(4):1029-1032. doi: 10.1177/1078155220957726. Epub 2020 Sep 21. J Oncol Pharm Pract. 2021. PMID: 32951520
[No title available]
[No authors listed] [No authors listed] PMID: 35980550
A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
Jung L, Miske A, Indorf A, Nelson K, Gadi VK, Banda K. Jung L, et al. Among authors: banda k. Clin Breast Cancer. 2022 Apr;22(3):e310-e318. doi: 10.1016/j.clbc.2021.09.007. Epub 2021 Sep 22. Clin Breast Cancer. 2022. PMID: 34753632
70 results